Potential Role for Combined Subtype-Selective Targeting of M and M Muscarinic Receptors in Gastrointestinal and Liver Diseases
JournalFrontiers in Pharmacology
PublisherFrontiers Media S.A.
MetadataShow full item record
AbstractDespite structural similarity, the five subtypes comprising the cholinergic muscarinic family of G protein-coupled receptors regulate remarkably diverse biological functions. This mini review focuses on the closely related and commonly co-expressed M1R and M3R muscarinic acetylcholine receptor subtypes encoded respectively by CHRM1 and CHRM3. Activated M1R and M3R signal via Gq and downstream initiate phospholipid turnover, changes in cell calcium levels, and activation of protein kinases that alter gene transcription and ultimately cell function. The unexpectedly divergent effects of M1R and M3R activation, despite similar receptor structure, distribution, and signaling, are puzzling. To explore this conundrum, we focus on the gastrointestinal (GI) tract and liver because abundant data identify opposing effects of M1R and M3R activation on the progression of gastric, pancreatic, and colon cancer, and liver injury and fibrosis. Whereas M3R activation promotes GI neoplasia, M1R activation appears protective. In contrast, in murine liver injury models, M3R activation promotes and M1R activation mitigates liver fibrosis. We analyze these findings critically, consider their therapeutic implications, and review the pharmacology and availability for research and therapeutics of M1R and M3R-selective agonists and antagonists. We conclude by considering gaps in knowledge and other factors that hinder the application of these drugs and the development of new agents to treat GI and liver diseases.
Rights/TermsCopyright © 2021 Tolaymat, Sundel, Alizadeh, Xie and Raufman.
KeywordG protein-coupled receptors
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/17251
- Cholinergic agonist-induced pepsinogen secretion from murine gastric chief cells is mediated by M1 and M3 muscarinic receptors.
- Authors: Xie G, Drachenberg C, Yamada M, Wess J, Raufman JP
- Issue date: 2005 Sep
- Divergent effects of muscarinic receptor subtype gene ablation on murine colon tumorigenesis reveals association of M3R and zinc finger protein 277 expression in colon neoplasia.
- Authors: Cheng K, Xie G, Khurana S, Heath J, Drachenberg CB, Timmons J, Shah N, Raufman JP
- Issue date: 2014 Apr 3
- Teaching an Old Drug New Tricks: Agonism, Antagonism, and Biased Signaling of Pilocarpine through M3 Muscarinic Acetylcholine Receptor.
- Authors: Pronin AN, Wang Q, Slepak VZ
- Issue date: 2017 Nov
- Evidence that anti-muscarinic antibodies in Sjögren's syndrome recognise both M3R and M1R.
- Authors: Schegg V, Vogel M, Didichenko S, Stadler MB, Beleznay Z, Gadola S, Sengupta C, Stadler BM, Miescher SM
- Issue date: 2008 Jul
- Mechanistic Clues Provided by Concurrent Changes in the Expression of Genes Encoding the M<sub>1</sub> Muscarinic Receptor, β-Catenin Signaling Proteins, and Downstream Targets in Adenocarcinomas of the Colon.
- Authors: Alizadeh M, Schledwitz A, Cheng K, Raufman JP
- Issue date: 2022